Angus J Turnbull1, Eddie Donaghy2, Lisa Salisbury3, Pamela Ramsay4, Janice Rattray5, Timothy Walsh6, Nazir Lone2. 1. University Department of Anaesthesia, Critical Care and Pain Medicine, Deanery of Clinical Sciences, University of Edinburgh, Edinburgh, UK. Electronic address: angus.turnbull2@nhs.scot. 2. University Department of Anaesthesia, Critical Care and Pain Medicine, Deanery of Clinical Sciences, University of Edinburgh, Edinburgh, UK; Usher Institute, University of Edinburgh, Edinburgh, UK. 3. School of Health Sciences, Queen Margaret University Edinburgh, Musselburgh, UK. 4. School of Health and Social Care, Edinburgh Napier University, Edinburgh, UK. 5. School of Nursing and Health Sciences, University of Dundee, Dundee, UK. 6. University Department of Anaesthesia, Critical Care and Pain Medicine, Deanery of Clinical Sciences, University of Edinburgh, Edinburgh, UK; Usher Institute, University of Edinburgh, Edinburgh, UK; MRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK.
Abstract
BACKGROUND: Polypharmacy is common and closely linked to drug interactions. The impact of polypharmacy has not been previously quantified in survivors of critical illness who have reduced resilience to stressors. Our aim was to identify factors associated with preadmission polypharmacy and ascertain whether polypharmacy is an independent risk factor for emergency readmission to hospital after discharge from a critical illness. METHODS: A population-wide cohort study consisting of patients admitted to all Scottish general ICUs between January 1, 2011 and December 31, 2013, whom survived their ICU stay. Patients were stratified by presence of preadmission polypharmacy, defined as being prescribed five or more regular medications. The primary outcome was emergency hospital readmission within 1 yr of discharge from index hospital stay. RESULTS: Of 23 844 ICU patients, 29.9% were identified with polypharmacy (n=7138). Factors associated with polypharmacy included female sex, increasing age, and social deprivation. Emergency 1-yr hospital readmission was significantly higher in the polypharmacy cohort (51.8% vs 35.8%, P<0.001). After confounder adjustment, patients with polypharmacy had a 22% higher hazard of emergency 1-yr readmission (adjusted hazard ratio 1.22, 95% confidence interval 1.16-1.28, P<0.001). On a linear scale of polypharmacy each additional prescription conferred a 3% increase in hazard of emergency readmission by 1 yr (adjusted hazard ratio 1.03, 95% confidence interval 1.02-1.03, P<0.001). CONCLUSIONS: This national cohort study of ICU survivors demonstrates that preadmission polypharmacy is an independent risk factor for emergency readmission. In an ever-growing era of polypharmacy, this risk factor may represent a substantial burden in the at-risk post-intensive care population.
BACKGROUND: Polypharmacy is common and closely linked to drug interactions. The impact of polypharmacy has not been previously quantified in survivors of critical illness who have reduced resilience to stressors. Our aim was to identify factors associated with preadmission polypharmacy and ascertain whether polypharmacy is an independent risk factor for emergency readmission to hospital after discharge from a critical illness. METHODS: A population-wide cohort study consisting of patients admitted to all Scottish general ICUs between January 1, 2011 and December 31, 2013, whom survived their ICU stay. Patients were stratified by presence of preadmission polypharmacy, defined as being prescribed five or more regular medications. The primary outcome was emergency hospital readmission within 1 yr of discharge from index hospital stay. RESULTS: Of 23 844 ICU patients, 29.9% were identified with polypharmacy (n=7138). Factors associated with polypharmacy included female sex, increasing age, and social deprivation. Emergency 1-yr hospital readmission was significantly higher in the polypharmacy cohort (51.8% vs 35.8%, P<0.001). After confounder adjustment, patients with polypharmacy had a 22% higher hazard of emergency 1-yr readmission (adjusted hazard ratio 1.22, 95% confidence interval 1.16-1.28, P<0.001). On a linear scale of polypharmacy each additional prescription conferred a 3% increase in hazard of emergency readmission by 1 yr (adjusted hazard ratio 1.03, 95% confidence interval 1.02-1.03, P<0.001). CONCLUSIONS: This national cohort study of ICU survivors demonstrates that preadmission polypharmacy is an independent risk factor for emergency readmission. In an ever-growing era of polypharmacy, this risk factor may represent a substantial burden in the at-risk post-intensive care population.
Authors: Nazir I Lone; Robert Lee; Lisa Salisbury; Eddie Donaghy; Pamela Ramsay; Janice Rattray; Timothy S Walsh Journal: Thorax Date: 2018-04-05 Impact factor: 9.139
Authors: Paolo Fabbietti; Giuseppina Di Stefano; Raffaella Moresi; Laura Cassetta; Mirko Di Rosa; Filippo Fimognari; Valentina Bambara; Giovanni Ruotolo; Alberto Castagna; Carmen Ruberto; Fabrizia Lattanzio; Andrea Corsonello Journal: Aging Clin Exp Res Date: 2017-11-11 Impact factor: 3.636
Authors: Arti Phatak; Rachael Prusi; Brooke Ward; Luke O Hansen; Mark V Williams; Elizabeth Vetter; Noelle Chapman; Michael Postelnick Journal: J Hosp Med Date: 2015-10-05 Impact factor: 2.960
Authors: Esther V Uijtendaal; Lieke L M van Harssel; Gerard W K Hugenholtz; Emile M Kuck; Jeannette E F Zwart-van Rijkom; Olaf L Cremer; Toine C G Egberts Journal: Pharmacotherapy Date: 2014-01-04 Impact factor: 4.705
Authors: Timothy S Walsh; Lisa Salisbury; Eddie Donaghy; Pamela Ramsay; Robert Lee; Janice Rattray; Nazir Lone Journal: BMJ Open Date: 2016-06-28 Impact factor: 2.692
Authors: Amir Hossein Miri; Mojtaba Kamankesh; Antoni Llopis-Lorente; Chenguang Liu; Matthias G Wacker; Ismaeil Haririan; Hamid Asadzadeh Aghdaei; Michael R Hamblin; Abbas Yadegar; Mazda Rad-Malekshahi; Mohammad Reza Zali Journal: Front Pharmacol Date: 2022-06-27 Impact factor: 5.988
Authors: Paula Luiza Menezes Cruz; Bruna Lúcia de Mendonça Soares; Jacqueline Elineuza da Silva; Renata Reis de Lima E Silva Journal: Eur J Clin Nutr Date: 2021-05-26 Impact factor: 4.016
Authors: Timothy Simon Walsh; Ellen Pauley; Eddie Donaghy; Joanne Thompson; Lucy Barclay; Richard Anthony Parker; Christopher Weir; James Marple Journal: BMJ Open Date: 2022-03-23 Impact factor: 2.692
Authors: Richard S Bourne; Jennifer K Jennings; Maria Panagioti; Alexander Hodkinson; Anthea Sutton; Darren M Ashcroft Journal: BMJ Qual Saf Date: 2022-01-18 Impact factor: 7.418